Additional weekly TLR3/CD40 stimulation once or twice following ISIM did not improve tumor response compared to mice treated with ISIM once in AT-3 tumor-bearing mice (Supplementary Fig. 19a). The gene discussed is CD40; the disease is neoplasm.